Jacobs Levy Equity Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-870,183
Closed -$55.8M 1107
2018
Q4
$55.8M Buy
870,183
+374,460
+76% +$27.6M 0.98% 9
2018
Q3
$44.4M Buy
495,723
+42,950
+9% +$3.8M 0.63% 21
2018
Q2
$36M Buy
452,773
+48,200
+12% +$4M 0.57% 22
2018
Q1
$36.1M Buy
404,573
+152,820
+61% +$14.7M 0.6% 17
2017
Q4
$26.3M Buy
251,753
+85,830
+52% +$9.68M 0.46% 47
2017
Q3
$24.2M Sell
165,923
-101,209
-38% -$13.8M 0.47% 49
2017
Q2
$34.7M Buy
267,132
+19,840
+8% +$2.43M 0.74% 10
2017
Q1
$30.8M Buy
247,292
+238,807
+2,814% +$28.6M 0.62% 24
2016
Q4
$982K Buy
8,485
+2,020
+31% +$225K 0.02% 555
2016
Q3
$676K Buy
+6,465
New +$700K 0.01% 656
2016
Q2
Sell
-90,419
Closed -$9.05M 1326
2016
Q1
$9.05M Sell
90,419
-120,826
-57% -$12.4M 0.19% 157
2015
Q4
$25.3M Sell
211,245
-17,360
-8% -$2.01M 0.5% 57
2015
Q3
$24.7M Sell
228,605
-207,046
-48% -$25.7M 0.51% 52
2015
Q2
$50.4M Sell
435,651
-70,050
-14% -$8.01M 0.96% 16
2015
Q1
$58.3M Buy
505,701
+11,423
+2% +$1.36M 0.99% 14
2014
Q4
$55.3M Sell
494,278
-78,820
-14% -$8.31M 0.95% 16
2014
Q3
$54.3M Sell
573,098
-85,474
-13% -$7.71M 0.91% 16
2014
Q2
$56.6M Sell
658,572
-66,170
-9% -$5.03M 0.94% 10
2014
Q1
$50.6M Sell
724,742
-6,376
-0.9% -$505K 0.85% 14
2013
Q4
$61.8M Sell
731,118
-16,668
-2% -$1.32M 0.93% 6
2013
Q3
$57.6M Sell
747,786
-23,656
-3% -$1.66M 0.98% 6
2013
Q2
$45.1M Buy
+771,442
New +$46.4M 0.8% 17

Other funds holding CELG

Jacobs Levy Equity Management's CELG Position: Q1 2019 in Review

Jacobs Levy Equity Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 870,183 shares — an estimated $55.8M sold.

Jacobs Levy Equity Management first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $61.8M in Q4 2013. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Jacobs Levy Equity Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 870,183 Celgene Corp shares in Q1 2019, an estimated $55.8M.
  • Jacobs Levy Equity Management first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
  • Jacobs Levy Equity Management's Celgene Corp position peaked at $61.8M in Q4 2013.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.